img

Global Pet NSAIDs Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Pet NSAIDs Market Insights, Forecast to 2034

Pet Non-steroidal anti-inflammatory drugs (NSAIDs) are medicines that are widely used to relieve pain, reduce inflammation, and bring down a high temperature. They can relieve the pain caused by inflammation of the pet's knee joint.
Global Pet NSAIDs market is expected to reach to US$ 38 million in 2024, with a positive growth of %, compared with US$ 35 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Pet NSAIDs industry is evaluated to reach US$ 48 million in 2029. The CAGR will be 4.1% during 2024 to 2029.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2024, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 46%.
Report Covers
This report presents an overview of global Pet NSAIDs market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Pet NSAIDs market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Zoetis
Elanco
PREVICOX
Metacam
Chanelle Pharma
AVENTIX
Woodruff
KRKA UK Ltd
Dechra
Parnell
VetUK
Norbrook
Alivira Animal Health
Vedco Inc
Vethical
Vetoquinol
Pivetal
Segment by Type
Carprofen
Deracoxib
Firocoxib
Meloxicam

Segment by Application


Dog
Cat
Horse
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Pet NSAIDs plant distribution, commercial date of Pet NSAIDs, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Pet NSAIDs introduction, etc. Pet NSAIDs Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Pet NSAIDs
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Pet NSAIDs Product Introduction
1.2 Market by Type
1.2.1 Global Pet NSAIDs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Carprofen
1.2.3 Deracoxib
1.2.4 Firocoxib
1.2.5 Meloxicam
1.3 Market by Application
1.3.1 Global Pet NSAIDs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Dog
1.3.3 Cat
1.3.4 Horse
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Pet NSAIDs Sales Estimates and Forecasts 2018-2029
2.2 Global Pet NSAIDs Revenue by Region
2.2.1 Global Pet NSAIDs Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Pet NSAIDs Revenue by Region (2018-2024)
2.2.3 Global Pet NSAIDs Revenue by Region (2024-2029)
2.2.4 Global Pet NSAIDs Revenue Market Share by Region (2018-2029)
2.3 Global Pet NSAIDs Sales Estimates and Forecasts 2018-2029
2.4 Global Pet NSAIDs Sales by Region
2.4.1 Global Pet NSAIDs Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Pet NSAIDs Sales by Region (2018-2024)
2.4.3 Global Pet NSAIDs Sales by Region (2024-2029)
2.4.4 Global Pet NSAIDs Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Pet NSAIDs Sales by Manufacturers
3.1.1 Global Pet NSAIDs Sales by Manufacturers (2018-2024)
3.1.2 Global Pet NSAIDs Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pet NSAIDs in 2022
3.2 Global Pet NSAIDs Revenue by Manufacturers
3.2.1 Global Pet NSAIDs Revenue by Manufacturers (2018-2024)
3.2.2 Global Pet NSAIDs Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Pet NSAIDs Revenue in 2022
3.3 Global Key Players of Pet NSAIDs, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Pet NSAIDs Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Pet NSAIDs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Pet NSAIDs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Pet NSAIDs, Product Offered and Application
3.8 Global Key Manufacturers of Pet NSAIDs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Pet NSAIDs Sales by Type
4.1.1 Global Pet NSAIDs Historical Sales by Type (2018-2024)
4.1.2 Global Pet NSAIDs Forecasted Sales by Type (2024-2029)
4.1.3 Global Pet NSAIDs Sales Market Share by Type (2018-2029)
4.2 Global Pet NSAIDs Revenue by Type
4.2.1 Global Pet NSAIDs Historical Revenue by Type (2018-2024)
4.2.2 Global Pet NSAIDs Forecasted Revenue by Type (2024-2029)
4.2.3 Global Pet NSAIDs Revenue Market Share by Type (2018-2029)
4.3 Global Pet NSAIDs Price by Type
4.3.1 Global Pet NSAIDs Price by Type (2018-2024)
4.3.2 Global Pet NSAIDs Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Pet NSAIDs Sales by Application
5.1.1 Global Pet NSAIDs Historical Sales by Application (2018-2024)
5.1.2 Global Pet NSAIDs Forecasted Sales by Application (2024-2029)
5.1.3 Global Pet NSAIDs Sales Market Share by Application (2018-2029)
5.2 Global Pet NSAIDs Revenue by Application
5.2.1 Global Pet NSAIDs Historical Revenue by Application (2018-2024)
5.2.2 Global Pet NSAIDs Forecasted Revenue by Application (2024-2029)
5.2.3 Global Pet NSAIDs Revenue Market Share by Application (2018-2029)
5.3 Global Pet NSAIDs Price by Application
5.3.1 Global Pet NSAIDs Price by Application (2018-2024)
5.3.2 Global Pet NSAIDs Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Pet NSAIDs Market Size by Type
6.1.1 US & Canada Pet NSAIDs Sales by Type (2018-2029)
6.1.2 US & Canada Pet NSAIDs Revenue by Type (2018-2029)
6.2 US & Canada Pet NSAIDs Market Size by Application
6.2.1 US & Canada Pet NSAIDs Sales by Application (2018-2029)
6.2.2 US & Canada Pet NSAIDs Revenue by Application (2018-2029)
6.3 US & Canada Pet NSAIDs Market Size by Country
6.3.1 US & Canada Pet NSAIDs Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Pet NSAIDs Sales by Country (2018-2029)
6.3.3 US & Canada Pet NSAIDs Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Pet NSAIDs Market Size by Type
7.1.1 Europe Pet NSAIDs Sales by Type (2018-2029)
7.1.2 Europe Pet NSAIDs Revenue by Type (2018-2029)
7.2 Europe Pet NSAIDs Market Size by Application
7.2.1 Europe Pet NSAIDs Sales by Application (2018-2029)
7.2.2 Europe Pet NSAIDs Revenue by Application (2018-2029)
7.3 Europe Pet NSAIDs Market Size by Country
7.3.1 Europe Pet NSAIDs Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Pet NSAIDs Sales by Country (2018-2029)
7.3.3 Europe Pet NSAIDs Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Pet NSAIDs Market Size
8.1.1 China Pet NSAIDs Sales (2018-2029)
8.1.2 China Pet NSAIDs Revenue (2018-2029)
8.2 China Pet NSAIDs Market Size by Application
8.2.1 China Pet NSAIDs Sales by Application (2018-2029)
8.2.2 China Pet NSAIDs Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Pet NSAIDs Market Size by Type
9.1.1 Asia Pet NSAIDs Sales by Type (2018-2029)
9.1.2 Asia Pet NSAIDs Revenue by Type (2018-2029)
9.2 Asia Pet NSAIDs Market Size by Application
9.2.1 Asia Pet NSAIDs Sales by Application (2018-2029)
9.2.2 Asia Pet NSAIDs Revenue by Application (2018-2029)
9.3 Asia Pet NSAIDs Sales by Region
9.3.1 Asia Pet NSAIDs Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Pet NSAIDs Revenue by Region (2018-2029)
9.3.3 Asia Pet NSAIDs Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Pet NSAIDs Market Size by Type
10.1.1 Middle East, Africa and Latin America Pet NSAIDs Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Pet NSAIDs Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Pet NSAIDs Market Size by Application
10.2.1 Middle East, Africa and Latin America Pet NSAIDs Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Pet NSAIDs Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Pet NSAIDs Sales by Country
10.3.1 Middle East, Africa and Latin America Pet NSAIDs Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Pet NSAIDs Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Pet NSAIDs Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Zoetis
11.1.1 Zoetis Company Information
11.1.2 Zoetis Overview
11.1.3 Zoetis Pet NSAIDs Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Zoetis Pet NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Zoetis Recent Developments
11.2 Elanco
11.2.1 Elanco Company Information
11.2.2 Elanco Overview
11.2.3 Elanco Pet NSAIDs Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Elanco Pet NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Elanco Recent Developments
11.3 PREVICOX
11.3.1 PREVICOX Company Information
11.3.2 PREVICOX Overview
11.3.3 PREVICOX Pet NSAIDs Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 PREVICOX Pet NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 PREVICOX Recent Developments
11.4 Metacam
11.4.1 Metacam Company Information
11.4.2 Metacam Overview
11.4.3 Metacam Pet NSAIDs Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Metacam Pet NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Metacam Recent Developments
11.5 Chanelle Pharma
11.5.1 Chanelle Pharma Company Information
11.5.2 Chanelle Pharma Overview
11.5.3 Chanelle Pharma Pet NSAIDs Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Chanelle Pharma Pet NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Chanelle Pharma Recent Developments
11.6 AVENTIX
11.6.1 AVENTIX Company Information
11.6.2 AVENTIX Overview
11.6.3 AVENTIX Pet NSAIDs Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 AVENTIX Pet NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 AVENTIX Recent Developments
11.7 Woodruff
11.7.1 Woodruff Company Information
11.7.2 Woodruff Overview
11.7.3 Woodruff Pet NSAIDs Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Woodruff Pet NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Woodruff Recent Developments
11.8 KRKA UK Ltd
11.8.1 KRKA UK Ltd Company Information
11.8.2 KRKA UK Ltd Overview
11.8.3 KRKA UK Ltd Pet NSAIDs Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 KRKA UK Ltd Pet NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 KRKA UK Ltd Recent Developments
11.9 Dechra
11.9.1 Dechra Company Information
11.9.2 Dechra Overview
11.9.3 Dechra Pet NSAIDs Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Dechra Pet NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Dechra Recent Developments
11.10 Parnell
11.10.1 Parnell Company Information
11.10.2 Parnell Overview
11.10.3 Parnell Pet NSAIDs Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Parnell Pet NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Parnell Recent Developments
11.11 VetUK
11.11.1 VetUK Company Information
11.11.2 VetUK Overview
11.11.3 VetUK Pet NSAIDs Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 VetUK Pet NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 VetUK Recent Developments
11.12 Norbrook
11.12.1 Norbrook Company Information
11.12.2 Norbrook Overview
11.12.3 Norbrook Pet NSAIDs Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Norbrook Pet NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Norbrook Recent Developments
11.13 Alivira Animal Health
11.13.1 Alivira Animal Health Company Information
11.13.2 Alivira Animal Health Overview
11.13.3 Alivira Animal Health Pet NSAIDs Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Alivira Animal Health Pet NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Alivira Animal Health Recent Developments
11.14 Vedco Inc
11.14.1 Vedco Inc Company Information
11.14.2 Vedco Inc Overview
11.14.3 Vedco Inc Pet NSAIDs Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Vedco Inc Pet NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Vedco Inc Recent Developments
11.15 Vethical
11.15.1 Vethical Company Information
11.15.2 Vethical Overview
11.15.3 Vethical Pet NSAIDs Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Vethical Pet NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Vethical Recent Developments
11.16 Vetoquinol
11.16.1 Vetoquinol Company Information
11.16.2 Vetoquinol Overview
11.16.3 Vetoquinol Pet NSAIDs Sales, Price, Revenue and Gross Margin (2018-2024)
11.16.4 Vetoquinol Pet NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Vetoquinol Recent Developments
11.17 Pivetal
11.17.1 Pivetal Company Information
11.17.2 Pivetal Overview
11.17.3 Pivetal Pet NSAIDs Sales, Price, Revenue and Gross Margin (2018-2024)
11.17.4 Pivetal Pet NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Pivetal Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Pet NSAIDs Industry Chain Analysis
12.2 Pet NSAIDs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pet NSAIDs Production Mode & Process
12.4 Pet NSAIDs Sales and Marketing
12.4.1 Pet NSAIDs Sales Channels
12.4.2 Pet NSAIDs Distributors
12.5 Pet NSAIDs Customers
13 Market Dynamics
13.1 Pet NSAIDs Industry Trends
13.2 Pet NSAIDs Market Drivers
13.3 Pet NSAIDs Market Challenges
13.4 Pet NSAIDs Market Restraints
14 Key Findings in The Global Pet NSAIDs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Pet NSAIDs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Carprofen
Table 3. Major Manufacturers of Deracoxib
Table 4. Major Manufacturers of Firocoxib
Table 5. Major Manufacturers of Meloxicam
Table 6. Global Pet NSAIDs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Pet NSAIDs Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Pet NSAIDs Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Pet NSAIDs Revenue by Region (2024-2029) & (US$ Million)
Table 10. Global Pet NSAIDs Revenue Market Share by Region (2018-2024)
Table 11. Global Pet NSAIDs Revenue Market Share by Region (2024-2029)
Table 12. Global Pet NSAIDs Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Pet NSAIDs Sales by Region (2018-2024) & (K Units)
Table 14. Global Pet NSAIDs Sales by Region (2024-2029) & (K Units)
Table 15. Global Pet NSAIDs Sales Market Share by Region (2018-2024)
Table 16. Global Pet NSAIDs Sales Market Share by Region (2024-2029)
Table 17. Global Pet NSAIDs Sales by Manufacturers (2018-2024) & (K Units)
Table 18. Global Pet NSAIDs Sales Share by Manufacturers (2018-2024)
Table 19. Global Pet NSAIDs Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Pet NSAIDs Revenue Share by Manufacturers (2018-2024)
Table 21. Global Key Players of Pet NSAIDs, Industry Ranking, 2021 VS 2022 VS 2024
Table 22. Pet NSAIDs Price by Manufacturers 2018-2024 (US$/Unit)
Table 23. Global Pet NSAIDs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Pet NSAIDs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet NSAIDs as of 2022)
Table 25. Global Key Manufacturers of Pet NSAIDs, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Pet NSAIDs, Product Offered and Application
Table 27. Global Key Manufacturers of Pet NSAIDs, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Pet NSAIDs Sales by Type (2018-2024) & (K Units)
Table 30. Global Pet NSAIDs Sales by Type (2024-2029) & (K Units)
Table 31. Global Pet NSAIDs Sales Share by Type (2018-2024)
Table 32. Global Pet NSAIDs Sales Share by Type (2024-2029)
Table 33. Global Pet NSAIDs Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Pet NSAIDs Revenue by Type (2024-2029) & (US$ Million)
Table 35. Global Pet NSAIDs Revenue Share by Type (2018-2024)
Table 36. Global Pet NSAIDs Revenue Share by Type (2024-2029)
Table 37. Pet NSAIDs Price by Type (2018-2024) & (US$/Unit)
Table 38. Global Pet NSAIDs Price Forecast by Type (2024-2029) & (US$/Unit)
Table 39. Global Pet NSAIDs Sales by Application (2018-2024) & (K Units)
Table 40. Global Pet NSAIDs Sales by Application (2024-2029) & (K Units)
Table 41. Global Pet NSAIDs Sales Share by Application (2018-2024)
Table 42. Global Pet NSAIDs Sales Share by Application (2024-2029)
Table 43. Global Pet NSAIDs Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Pet NSAIDs Revenue by Application (2024-2029) & (US$ Million)
Table 45. Global Pet NSAIDs Revenue Share by Application (2018-2024)
Table 46. Global Pet NSAIDs Revenue Share by Application (2024-2029)
Table 47. Pet NSAIDs Price by Application (2018-2024) & (US$/Unit)
Table 48. Global Pet NSAIDs Price Forecast by Application (2024-2029) & (US$/Unit)
Table 49. US & Canada Pet NSAIDs Sales by Type (2018-2024) & (K Units)
Table 50. US & Canada Pet NSAIDs Sales by Type (2024-2029) & (K Units)
Table 51. US & Canada Pet NSAIDs Revenue by Type (2018-2024) & (US$ Million)
Table 52. US & Canada Pet NSAIDs Revenue by Type (2024-2029) & (US$ Million)
Table 53. US & Canada Pet NSAIDs Sales by Application (2018-2024) & (K Units)
Table 54. US & Canada Pet NSAIDs Sales by Application (2024-2029) & (K Units)
Table 55. US & Canada Pet NSAIDs Revenue by Application (2018-2024) & (US$ Million)
Table 56. US & Canada Pet NSAIDs Revenue by Application (2024-2029) & (US$ Million)
Table 57. US & Canada Pet NSAIDs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. US & Canada Pet NSAIDs Revenue by Country (2018-2024) & (US$ Million)
Table 59. US & Canada Pet NSAIDs Revenue by Country (2024-2029) & (US$ Million)
Table 60. US & Canada Pet NSAIDs Sales by Country (2018-2024) & (K Units)
Table 61. US & Canada Pet NSAIDs Sales by Country (2024-2029) & (K Units)
Table 62. Europe Pet NSAIDs Sales by Type (2018-2024) & (K Units)
Table 63. Europe Pet NSAIDs Sales by Type (2024-2029) & (K Units)
Table 64. Europe Pet NSAIDs Revenue by Type (2018-2024) & (US$ Million)
Table 65. Europe Pet NSAIDs Revenue by Type (2024-2029) & (US$ Million)
Table 66. Europe Pet NSAIDs Sales by Application (2018-2024) & (K Units)
Table 67. Europe Pet NSAIDs Sales by Application (2024-2029) & (K Units)
Table 68. Europe Pet NSAIDs Revenue by Application (2018-2024) & (US$ Million)
Table 69. Europe Pet NSAIDs Revenue by Application (2024-2029) & (US$ Million)
Table 70. Europe Pet NSAIDs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe Pet NSAIDs Revenue by Country (2018-2024) & (US$ Million)
Table 72. Europe Pet NSAIDs Revenue by Country (2024-2029) & (US$ Million)
Table 73. Europe Pet NSAIDs Sales by Country (2018-2024) & (K Units)
Table 74. Europe Pet NSAIDs Sales by Country (2024-2029) & (K Units)
Table 75. China Pet NSAIDs Sales by Type (2018-2024) & (K Units)
Table 76. China Pet NSAIDs Sales by Type (2024-2029) & (K Units)
Table 77. China Pet NSAIDs Revenue by Type (2018-2024) & (US$ Million)
Table 78. China Pet NSAIDs Revenue by Type (2024-2029) & (US$ Million)
Table 79. China Pet NSAIDs Sales by Application (2018-2024) & (K Units)
Table 80. China Pet NSAIDs Sales by Application (2024-2029) & (K Units)
Table 81. China Pet NSAIDs Revenue by Application (2018-2024) & (US$ Million)
Table 82. China Pet NSAIDs Revenue by Application (2024-2029) & (US$ Million)
Table 83. Asia Pet NSAIDs Sales by Type (2018-2024) & (K Units)
Table 84. Asia Pet NSAIDs Sales by Type (2024-2029) & (K Units)
Table 85. Asia Pet NSAIDs Revenue by Type (2018-2024) & (US$ Million)
Table 86. Asia Pet NSAIDs Revenue by Type (2024-2029) & (US$ Million)
Table 87. Asia Pet NSAIDs Sales by Application (2018-2024) & (K Units)
Table 88. Asia Pet NSAIDs Sales by Application (2024-2029) & (K Units)
Table 89. Asia Pet NSAIDs Revenue by Application (2018-2024) & (US$ Million)
Table 90. Asia Pet NSAIDs Revenue by Application (2024-2029) & (US$ Million)
Table 91. Asia Pet NSAIDs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 92. Asia Pet NSAIDs Revenue by Region (2018-2024) & (US$ Million)
Table 93. Asia Pet NSAIDs Revenue by Region (2024-2029) & (US$ Million)
Table 94. Asia Pet NSAIDs Sales by Region (2018-2024) & (K Units)
Table 95. Asia Pet NSAIDs Sales by Region (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Pet NSAIDs Sales by Type (2018-2024) & (K Units)
Table 97. Middle East, Africa and Latin America Pet NSAIDs Sales by Type (2024-2029) & (K Units)
Table 98. Middle East, Africa and Latin America Pet NSAIDs Revenue by Type (2018-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America Pet NSAIDs Revenue by Type (2024-2029) & (US$ Million)
Table 100. Middle East, Africa and Latin America Pet NSAIDs Sales by Application (2018-2024) & (K Units)
Table 101. Middle East, Africa and Latin America Pet NSAIDs Sales by Application (2024-2029) & (K Units)
Table 102. Middle East, Africa and Latin America Pet NSAIDs Revenue by Application (2018-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Pet NSAIDs Revenue by Application (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America Pet NSAIDs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 105. Middle East, Africa and Latin America Pet NSAIDs Revenue by Country (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Pet NSAIDs Revenue by Country (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Pet NSAIDs Sales by Country (2018-2024) & (K Units)
Table 108. Middle East, Africa and Latin America Pet NSAIDs Sales by Country (2024-2029) & (K Units)
Table 109. Zoetis Company Information
Table 110. Zoetis Description and Major Businesses
Table 111. Zoetis Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 112. Zoetis Pet NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Zoetis Recent Developments
Table 114. Elanco Company Information
Table 115. Elanco Description and Major Businesses
Table 116. Elanco Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 117. Elanco Pet NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Elanco Recent Developments
Table 119. PREVICOX Company Information
Table 120. PREVICOX Description and Major Businesses
Table 121. PREVICOX Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 122. PREVICOX Pet NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. PREVICOX Recent Developments
Table 124. Metacam Company Information
Table 125. Metacam Description and Major Businesses
Table 126. Metacam Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 127. Metacam Pet NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Metacam Recent Developments
Table 129. Chanelle Pharma Company Information
Table 130. Chanelle Pharma Description and Major Businesses
Table 131. Chanelle Pharma Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 132. Chanelle Pharma Pet NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Chanelle Pharma Recent Developments
Table 134. AVENTIX Company Information
Table 135. AVENTIX Description and Major Businesses
Table 136. AVENTIX Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 137. AVENTIX Pet NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. AVENTIX Recent Developments
Table 139. Woodruff Company Information
Table 140. Woodruff Description and Major Businesses
Table 141. Woodruff Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 142. Woodruff Pet NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Woodruff Recent Developments
Table 144. KRKA UK Ltd Company Information
Table 145. KRKA UK Ltd Description and Major Businesses
Table 146. KRKA UK Ltd Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 147. KRKA UK Ltd Pet NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. KRKA UK Ltd Recent Developments
Table 149. Dechra Company Information
Table 150. Dechra Description and Major Businesses
Table 151. Dechra Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 152. Dechra Pet NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. Dechra Recent Developments
Table 154. Parnell Company Information
Table 155. Parnell Description and Major Businesses
Table 156. Parnell Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 157. Parnell Pet NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. Parnell Recent Developments
Table 159. VetUK Company Information
Table 160. VetUK Description and Major Businesses
Table 161. VetUK Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 162. VetUK Pet NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
Table 163. VetUK Recent Developments
Table 164. Norbrook Company Information
Table 165. Norbrook Description and Major Businesses
Table 166. Norbrook Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 167. Norbrook Pet NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
Table 168. Norbrook Recent Developments
Table 169. Alivira Animal Health Company Information
Table 170. Alivira Animal Health Description and Major Businesses
Table 171. Alivira Animal Health Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 172. Alivira Animal Health Pet NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
Table 173. Alivira Animal Health Recent Developments
Table 174. Vedco Inc Company Information
Table 175. Vedco Inc Description and Major Businesses
Table 176. Vedco Inc Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 177. Vedco Inc Pet NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
Table 178. Vedco Inc Recent Developments
Table 179. Vethical Company Information
Table 180. Vethical Description and Major Businesses
Table 181. Vethical Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 182. Vethical Pet NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
Table 183. Vethical Recent Developments
Table 184. Vetoquinol Company Information
Table 185. Vetoquinol Description and Major Businesses
Table 186. Vetoquinol Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 187. Vetoquinol Pet NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
Table 188. Vetoquinol Recent Developments
Table 189. Pivetal Company Information
Table 190. Pivetal Description and Major Businesses
Table 191. Pivetal Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 192. Pivetal Pet NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
Table 193. Pivetal Recent Developments
Table 194. Key Raw Materials Lists
Table 195. Raw Materials Key Suppliers Lists
Table 196. Pet NSAIDs Distributors List
Table 197. Pet NSAIDs Customers List
Table 198. Pet NSAIDs Market Trends
Table 199. Pet NSAIDs Market Drivers
Table 200. Pet NSAIDs Market Challenges
Table 201. Pet NSAIDs Market Restraints
Table 202. Research Programs/Design for This Report
Table 203. Key Data Information from Secondary Sources
Table 204. Key Data Information from Primary Sources
List of Figures
Figure 1. Pet NSAIDs Product Picture
Figure 2. Global Pet NSAIDs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Pet NSAIDs Market Share by Type in 2022 & 2029
Figure 4. Carprofen Product Picture
Figure 5. Deracoxib Product Picture
Figure 6. Firocoxib Product Picture
Figure 7. Meloxicam Product Picture
Figure 8. Global Pet NSAIDs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Pet NSAIDs Market Share by Application in 2022 & 2029
Figure 10. Dog
Figure 11. Cat
Figure 12. Horse
Figure 13. Others
Figure 14. Pet NSAIDs Report Years Considered
Figure 15. Global Pet NSAIDs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Pet NSAIDs Revenue 2018-2029 (US$ Million)
Figure 17. Global Pet NSAIDs Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 18. Global Pet NSAIDs Revenue Market Share by Region (2018-2029)
Figure 19. Global Pet NSAIDs Sales 2018-2029 ((K Units)
Figure 20. Global Pet NSAIDs Sales Market Share by Region (2018-2029)
Figure 21. US & Canada Pet NSAIDs Sales YoY (2018-2029) & (K Units)
Figure 22. US & Canada Pet NSAIDs Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Europe Pet NSAIDs Sales YoY (2018-2029) & (K Units)
Figure 24. Europe Pet NSAIDs Revenue YoY (2018-2029) & (US$ Million)
Figure 25. China Pet NSAIDs Sales YoY (2018-2029) & (K Units)
Figure 26. China Pet NSAIDs Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Asia (excluding China) Pet NSAIDs Sales YoY (2018-2029) & (K Units)
Figure 28. Asia (excluding China) Pet NSAIDs Revenue YoY (2018-2029) & (US$ Million)
Figure 29. Middle East, Africa and Latin America Pet NSAIDs Sales YoY (2018-2029) & (K Units)
Figure 30. Middle East, Africa and Latin America Pet NSAIDs Revenue YoY (2018-2029) & (US$ Million)
Figure 31. The Pet NSAIDs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 32. The Top 5 and 10 Largest Manufacturers of Pet NSAIDs in the World: Market Share by Pet NSAIDs Revenue in 2022
Figure 33. Global Pet NSAIDs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 34. Global Pet NSAIDs Sales Market Share by Type (2018-2029)
Figure 35. Global Pet NSAIDs Revenue Market Share by Type (2018-2029)
Figure 36. Global Pet NSAIDs Sales Market Share by Application (2018-2029)
Figure 37. Global Pet NSAIDs Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Pet NSAIDs Sales Market Share by Type (2018-2029)
Figure 39. US & Canada Pet NSAIDs Revenue Market Share by Type (2018-2029)
Figure 40. US & Canada Pet NSAIDs Sales Market Share by Application (2018-2029)
Figure 41. US & Canada Pet NSAIDs Revenue Market Share by Application (2018-2029)
Figure 42. US & Canada Pet NSAIDs Revenue Share by Country (2018-2029)
Figure 43. US & Canada Pet NSAIDs Sales Share by Country (2018-2029)
Figure 44. U.S. Pet NSAIDs Revenue (2018-2029) & (US$ Million)
Figure 45. Canada Pet NSAIDs Revenue (2018-2029) & (US$ Million)
Figure 46. Europe Pet NSAIDs Sales Market Share by Type (2018-2029)
Figure 47. Europe Pet NSAIDs Revenue Market Share by Type (2018-2029)
Figure 48. Europe Pet NSAIDs Sales Market Share by Application (2018-2029)
Figure 49. Europe Pet NSAIDs Revenue Market Share by Application (2018-2029)
Figure 50. Europe Pet NSAIDs Revenue Share by Country (2018-2029)
Figure 51. Europe Pet NSAIDs Sales Share by Country (2018-2029)
Figure 52. Germany Pet NSAIDs Revenue (2018-2029) & (US$ Million)
Figure 53. France Pet NSAIDs Revenue (2018-2029) & (US$ Million)
Figure 54. U.K. Pet NSAIDs Revenue (2018-2029) & (US$ Million)
Figure 55. Italy Pet NSAIDs Revenue (2018-2029) & (US$ Million)
Figure 56. Russia Pet NSAIDs Revenue (2018-2029) & (US$ Million)
Figure 57. China Pet NSAIDs Sales Market Share by Type (2018-2029)
Figure 58. China Pet NSAIDs Revenue Market Share by Type (2018-2029)
Figure 59. China Pet NSAIDs Sales Market Share by Application (2018-2029)
Figure 60. China Pet NSAIDs Revenue Market Share by Application (2018-2029)
Figure 61. Asia Pet NSAIDs Sales Market Share by Type (2018-2029)
Figure 62. Asia Pet NSAIDs Revenue Market Share by Type (2018-2029)
Figure 63. Asia Pet NSAIDs Sales Market Share by Application (2018-2029)
Figure 64. Asia Pet NSAIDs Revenue Market Share by Application (2018-2029)
Figure 65. Asia Pet NSAIDs Revenue Share by Region (2018-2029)
Figure 66. Asia Pet NSAIDs Sales Share by Region (2018-2029)
Figure 67. Japan Pet NSAIDs Revenue (2018-2029) & (US$ Million)
Figure 68. South Korea Pet NSAIDs Revenue (2018-2029) & (US$ Million)
Figure 69. China Taiwan Pet NSAIDs Revenue (2018-2029) & (US$ Million)
Figure 70. Southeast Asia Pet NSAIDs Revenue (2018-2029) & (US$ Million)
Figure 71. India Pet NSAIDs Revenue (2018-2029) & (US$ Million)
Figure 72. Middle East, Africa and Latin America Pet NSAIDs Sales Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Pet NSAIDs Revenue Market Share by Type (2018-2029)
Figure 74. Middle East, Africa and Latin America Pet NSAIDs Sales Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Pet NSAIDs Revenue Market Share by Application (2018-2029)
Figure 76. Middle East, Africa and Latin America Pet NSAIDs Revenue Share by Country (2018-2029)
Figure 77. Middle East, Africa and Latin America Pet NSAIDs Sales Share by Country (2018-2029)
Figure 78. Brazil Pet NSAIDs Revenue (2018-2029) & (US$ Million)
Figure 79. Mexico Pet NSAIDs Revenue (2018-2029) & (US$ Million)
Figure 80. Turkey Pet NSAIDs Revenue (2018-2029) & (US$ Million)
Figure 81. Israel Pet NSAIDs Revenue (2018-2029) & (US$ Million)
Figure 82. GCC Countries Pet NSAIDs Revenue (2018-2029) & (US$ Million)
Figure 83. Pet NSAIDs Value Chain
Figure 84. Pet NSAIDs Production Process
Figure 85. Channels of Distribution
Figure 86. Distributors Profiles
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed